These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 15193302

  • 21. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
    Zhang GX, Xiao BG, Yu LY, van der Meide PH, Link H.
    J Neuroimmunol; 2001 Feb 01; 113(1):10-8. PubMed ID: 11137572
    [Abstract] [Full Text] [Related]

  • 22. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T, Yeh TM, Krolick KA.
    J Immunol; 1991 Jan 15; 146(2):663-70. PubMed ID: 1987281
    [Abstract] [Full Text] [Related]

  • 23. CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.
    Milani M, Ostlie N, Wu H, Wang W, Conti-Fine BM.
    J Neuroimmunol; 2006 Oct 15; 179(1-2):152-62. PubMed ID: 16945426
    [Abstract] [Full Text] [Related]

  • 24. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S, McIntosh K, Drachman DB.
    Ann Neurol; 1994 Nov 15; 36(5):704-13. PubMed ID: 7979216
    [Abstract] [Full Text] [Related]

  • 25. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y, Lindstrom J.
    J Immunol; 1988 Mar 15; 140(6):1830-7. PubMed ID: 2450133
    [Abstract] [Full Text] [Related]

  • 26. [The mechanism of prophylactic effects of nasal tolerance with a dual analogue on experimental autoimmune myasthenia gravis in young mice].
    Liu SL, Huang Z.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr 15; 10(2):191-4. PubMed ID: 18433545
    [Abstract] [Full Text] [Related]

  • 27. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats.
    Zhang GX, Ma CG, Xiao BG, van de Meide PH, Link H.
    Eur J Immunol; 1996 Nov 15; 26(11):2552-8. PubMed ID: 8921938
    [Abstract] [Full Text] [Related]

  • 28. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
    Li N, Mu L, Wang J, Zhang J, Xie X, Kong Q, Tang W, Yao X, Liu Y, Wang L, Wang G, Wang D, Jin L, Sun B, Li H.
    Eur J Immunol; 2012 May 15; 42(5):1140-51. PubMed ID: 22539289
    [Abstract] [Full Text] [Related]

  • 29. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
    Im SH, Barchan D, Maiti PK, Raveh L, Souroujon MC, Fuchs S.
    FASEB J; 2001 Oct 15; 15(12):2140-8. PubMed ID: 11641240
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H.
    Ann N Y Acad Sci; 1996 Feb 13; 778():273-87. PubMed ID: 8610980
    [Abstract] [Full Text] [Related]

  • 32. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B, Deng C, Lee J, Christadoss P, Sarvetnick N.
    J Immunol; 1998 Sep 15; 161(6):2856-62. PubMed ID: 9743346
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production.
    Poussin MA, Goluszko E, David CS, Franco JU, Christadoss P.
    J Autoimmun; 2001 Nov 15; 17(3):175-80. PubMed ID: 11712854
    [Abstract] [Full Text] [Related]

  • 38. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB, Li H, He B, Bakheit M, Levi M, Wahren B, Berglöf A, Sandstedt K, Link H, Shi FD.
    Biomed Pharmacother; 1999 Jun 15; 53(5-6):227-33. PubMed ID: 10424244
    [Abstract] [Full Text] [Related]

  • 39. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Huang J, Olsson T, He B, Link H.
    J Neurol Sci; 1995 Feb 15; 128(2):167-74. PubMed ID: 7537794
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment.
    Maiti PK, Feferman T, Im SH, Souroujon MC, Fuchs S.
    J Neuroimmunol; 2004 Jul 15; 152(1-2):112-20. PubMed ID: 15223243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.